0000912282-24-000274.txt : 20240319
0000912282-24-000274.hdr.sgml : 20240319
20240319091742
ACCESSION NUMBER: 0000912282-24-000274
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240315
FILED AS OF DATE: 20240319
DATE AS OF CHANGE: 20240319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evans Daron
CENTRAL INDEX KEY: 0001411726
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39683
FILM NUMBER: 24761256
MAIL ADDRESS:
STREET 1: C/O NEPHROS, INC.
STREET 2: 380 LACKAWANNA PLACE
CITY: SOUTH ORANGE
STATE: NJ
ZIP: 07079
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rezolute, Inc.
CENTRAL INDEX KEY: 0001509261
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 273440894
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 275 SHORELINE DRIVE, SUITE 500
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-206-4507
MAIL ADDRESS:
STREET 1: 275 SHORELINE DRIVE, SUITE 500
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: AntriaBio, Inc.
DATE OF NAME CHANGE: 20130114
FORMER COMPANY:
FORMER CONFORMED NAME: FITS MY STYLE INC
DATE OF NAME CHANGE: 20110104
4
1
form4.xml
X0508
4
2024-03-15
0001509261
Rezolute, Inc.
RZLT
0001411726
Evans Daron
C/O REZOLUTE, INC.
275 SHORELINE DRIVE, SUITE 500
REDWOOD CITY
CA
94065
true
CFO
false
Common Shares
2024-03-15
4
P
0
20000
1.6915
A
20000
I
Held by spouse
Common Shares
120900
D
Common Shares
10000
I
Held by minor child #1
Common Shares
4500
I
Held by minor child #2
Common Shares
4500
I
Held by minor child #3
The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.69 to $1.70, inclusive. The reporting person undertakes to provide to Rezolute, Inc., any securityholder of Rezolute, Inc. or the staff of the Securities an Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
/s/ Daron Evans
2024-03-15